Evidation | Engaged Health Community

Our Community

Direct, ongoing connections to millions of individuals across 100+ conditions

Individuals consent to share health data, and in turn, receive meaningful value - through support, rewards, and greater control over their health.

The Evidation Community: an ongoing connection to 5M people

*Varies by population, protocol, and length of program; many of our recent programs have seen 90%+ engagement
*Conversion rate for “click to read” offers once offer is seen

Scaled

Characterized

Engaged

Our established, two-way connection with Members generates high-quality data and drives healthier actions.

Members are characterized based on dozens of variables, including but not limited to:

Demographics

Social Determinants of Health

Conditions & Treatment

Health & Lifestyle

See how we drive success for our customers:

Improving blood pressure in overweight individuals through a digital self-management program

Omada ran a pilot study run managed by Evidation to demonstrate the value of a digital hypertension self-management program by quantifying its impact on blood pressure control. As a result of this study, Omada was able to publish evidence that their app improves blood pressure and medication adherence.

FluSmart participants receive alerts and nudges to seek care

In partnership with BARDA, Evidation developed and deployed a flu monitoring program, FluSmart, within the Evidation Community to collect rich, longitudinal data and activate high-risk participants into research and care.

Helping cardiovascular patients better understand and act on their heart health

The American College of Cardiology (ACC) launched the Heart Health patient engagement program on the Evidation platform to allow patients to track their everyday health and proactively manage their care beyond traditional clinical settings.

Identifying and addressing gaps in the patient experience

Myovant uncovered significant unmet needs among individuals with uterine fibroids (UF) in a direct-to-patient 4-month study with 350 women living with UF.

Increasing treatment rates with co-created patient engagement

Evidation partnered with Sanofi to test and refine content and messaging for a Type 2 diabetes flu vaccine education program.

Creating the first large-scale, nationally representative digital health dataset

Evidation partnered with USC and the RAND Corporation on American Life in Real-time (ALiR), a first-of-its-kind, publicly available benchmark registry and research infrastructure for person-generated health data collected from smartphones and wearables to advance equitable precision health.

Developing an early warning algorithm for individuals at high risk for COVID-19

Evidation conducted a study to demonstrate that person-generated health data, including data from smartphones and wearable devices, has the potential to enable applications ranging from individual-level early warnings or population-level hotspot detection for COVID-19.

Exploring potential to reduce stroke risk with earlier detection of Afib

Evidation partnered with Johnson&Johnson to support a multi-year, observational study that sought to assess whether the Heartline™ Study app on iPhone, and the ECG app and irregular rhythm notification feature on Apple Watch, can reduce the likelihood of stroke and improve health outcomes with earlier detection of atrial fibrillation.

Measuring cognitive impairment with direct-from-patient real-world data

Evidation partnered with Eli Lilly to develop new endpoints and identify digital signals of cognitive impairment through the use of digital and wearable devices, mobile apps, and sleep sensors.

Better Understanding of the Metamorphosis of Pregnancy (BUMP)

Evidation partnered with 4YouandMe to provide a platform to manage data collection, processing, and storage for the BUMP longitudinal feasibility study aimed to gain a deeper understanding of the pre-pregnancy and pregnancy symptom experience using digital tools.

Developing more successful digital health programs with patient perspectives

Evidation partnered with Sanofi to get data-driven insights to prioritize program features and future development of a connected ecosystem for managing type 2 diabetes (T2D).

Therapeutic experience